footnoted*

A late Friday filing caught our attention for what it didn’t say: why the CEO is paid the same even though the stock has dropped 90%.

We are now offering a subset of our Pro data via Twitter. Find out more by clicking here: https://premosocial.com/footnotedFND

Once the grand temples to American consumerism, malls are in a decline that seems to have accelerated in 2017.

The company admits its news channels’ sexual harassment claims could take a toll.

Twitter’s use of a new phrase in recent earnings has caught our attention

Explaining executive raises following a controversy that sunk the stock gets awkward.

A recent arbitration decision hurt the company hard. More serious problems may be on the way.

A small biopharma company is hoping that its new CEO’s recent track record works a second time.

In the case of Valeant, a major investor paid a heavy price for ignoring the company’s endless Red Flags.

With no clear plan for ending or fixing Obamacare, a growing number of corporations are left guessing: “What’s next?”